Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial

Journal of Dietary Supplements

Volumn 13, Issue 1, 2016, Pages 93-105

  Panahi, Yunes ^a   Ghanei, Mostafa ^a   Hajhashemi, Ali ^a   Sahebkar, Amirhossein ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; ANTIOXIDANT; CURCUMIN; GLUTATHIONE; MALONALDEHYDE; MUSTARD GAS; PIPERIDINE DERIVATIVE; PIPERINE; PLANT EXTRACT; POLYPHENOL;

ADULT; BLOOD; BRONCHIOLITIS; CHEMISTRY; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CURCUMA; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HUMAN; LUNG FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PHYTOTHERAPY; PIPER (PLANT); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALKALOIDS; ANTIOXIDANTS; BENZODIOXOLES; BRONCHIOLITIS; CHRONIC DISEASE; CURCUMA; CURCUMIN; DOUBLE-BLIND METHOD; GLUTATHIONE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MUSTARD GAS; OXIDATIVE STRESS; PHYTOTHERAPY; PIPER; PIPERIDINES; PLANT EXTRACTS; POLYPHENOLS; POLYUNSATURATED ALKAMIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 84945497362     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2014.952865     Document Type: Article

References (67)

1. Akerboom TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Method Enzymol. 1981; 77: 373-382.
2. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4: 807-818.
3. Asouri M, Ataee R, Ahmadi AA, Amini A, Rezaei Moshaei M. Antioxidant and free radical scavenging activities of curcumin. Asian J Chem. 2013; 25: 7593-7595.
4. Balali-Mood M, Hefazi M. The clinical toxicology of sulfur mustard. Arch Iranian Med. 2005; 8: 162-179.
5. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, Razavi ME, Zare G, Tabatabaee A, Jaafari MR. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol. 2005; 19: 713-721.
6. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signaling 2005; 7: 32-41.
7. Bridgeman MM, Marsden M, MacNee W, Flenley DC, Ryle AP. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 1991; 46: 39-42.
8. Chance B, Maehly AC. Assay of catalase and peroxidase. In: SP Colowick, ND Kaplan. (Eds.), Methods in enzymology (Vol. 2). pp. 764-791, New York: Academic Press, 1995.
9. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012; 26: 1719-1725.
10. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001; 21: 2895-2900.
11. Corradi M, Rubinstein I, Andreoli R, Manini P, Caglieri A, Poli D, Alinovi R, Mutti A. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167: 1380-1386.
12. Emad A, Rezaian GR. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 1999; 115: 1346-1351.
13. Ghanei M, Ghayumi M, Ahakzani N, Rezvani O, Jafari M, Ani A, Aslani J. Noninvasive diagnosis of bronchiolitis obliterans due to sulfur mustard exposure: could high-resolution computed tomography give us a clue? La Radiologia Medica 2010; 115: 413-420.
14. Gillissen A, Jaworska M, Orth M, Coffiner M, Maes P, App EM, Cantin AM, Schultze-Werninghaus G. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir Med. 1997; 91: 159-168.
15. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013; 15: 195-218.
16. Guzel A, Kanter M, Yucel AF, Erboga M. Protective effect of curcumin on acute lung injury induced by intestinal ischaemia/reperfusion. Toxicol Ind Health 2013; 29: 633-642.
17. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol. 2000; 151: 975-981.
18. Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 2010; 17: 269-273.
19. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34: 648-654.
20. Kalpana C, Menon VP. Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem. 2004; 53: 82-86.
21. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med. 2003; 45: 1136-1143.
22. Lari SM, Attaran D, Towhidi M. COPD Due to Sulfur Mustard (Mustard Lung), Chronic Obstructive Pulmonary Disease-Current Concepts and Practice, Dr. Kian-Chung Ong (Ed.), (2012),. ISBN: 978-953-51-0163-5, InTech, DOI: 10.5772/29748. Available from: http://www.intechopen.com/books/chronic-obstructive-pulmonary-disease-current-concepts-and-practice/copd-due-to-sulfur-mustard-mustard-lung-
23. Lao CD, Ruffin MTt, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complem Altern Med. 2006; 6: 10.
24. Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, Solomides CC, Javvadi P, Koumenis C, Cengel KA, Christofidou-Solomidou M. Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiation Res. 2010; 173: 590-601.
25. MacNee W. Treatment of stable COPD: antioxidants. Eur Respir Rev. 2005; 14: 12-22.
26. MacNee W, Bridgeman MM, Marsden M, Drost E, Lannan S, Selby C, Donaldson K. The effects of N-acetylcysteine and glutathione on smoke-induced changes in lung phagocytes and epithelial cells. Am J Med. 1991; 91: 60S-66S.
27. Madan B, Ghosh B. Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock. Shock, 2003; 19: 91-96.
28. Manna SK, Kuo MT, Aggarwal BB. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene, 1999; 18: 4371-4382.
29. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George respiratory questionnaire. Chest 2007; 132: 456-463.
30. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007; 595: 105-125.
31. Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 2013; 27: 374-379.
32. Ng TP, Niti M, Yap KB, Tan WC. Curcumins-rich curry diet and pulmonary function in Asian older adults. PLoS One 2012; 7: e51753.
33. Panahi Y, Davoudi SM, Sahebkar A, Beiraghdar F, Dadjo Y, Feizi I, Amirchoopani G, Zamani A. Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial. Cutan Ocul Toxicol. 2012e; 31: 95-103.
34. Panahi Y, Ghanei M, Aslani J, Mojtahedzadeh M. The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas. Iran J Allergy Asthma Immunol. 2005; 4: 83-90.
35. Panahi Y, Ghanei M, Vahedi E, Ghazvini A, Parvin S, Madanchi N, Bagheri M, Sahebkar A. Effect of recombinant human IFNgamma in the treatment of chronic pulmonary complications due to sulfur mustard intoxication. J Immunotoxicol. 2014a; 11: 72-77.
36. Panahi Y, Saadat A, Beiraghdar F, Hosseini Nouzari SM, Jalalian HR, Sahebkar A. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: a randomized double-blind placebo-controlled trial. J Funct Foods, 2014b; 6: 615-622.
37. Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2012b; 108: 1272-1279.
38. Panahi Y, Sahebkar A, Davoudi SM, Amiri M, Beiraghdar F. Efficacy and safety of immunotherapy with interferon-gamma in the management of chronic sulfur mustard-induced cutaneous complications: comparison with topical betamethasone 1%. Scientific World Journal, 2012c; 2012: 285274.
39. Panahi Y, Sahebkar A, Parvin S, Saadat A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem. 2012a; 49: 580-588.
40. Panahi Y, Sarayani A, Beiraghdar F, Amiri M, Davoudi SM, Sahebkar A. Management of sulfur mustard-induced chronic pruritus: a review of clinical trials. Cutaneous Ocul Toxicol. 2012d; 31: 220-225.
41. Panahi Y, Badeli R, Karami N, Sahebkar A,. Investigation of the Efficacy of Adjunctive Therapy with Bioavailability-Boosted Curcuminoids in Major Depressive Disorder (2014) Phytotherapy Research. Doi: 10.1002/ptr.5211
42. Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar. A. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial (2014) Complementary Therapies in Medicine. Doi
43. Panahi Y, Rahimnia A, Sharafi M, Alishiri G, Saburi A, Sahebkar. A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytotherapy Research. (n.d.) Doi: 10.1002/ptr.5174
44. Poursaleh Z, Harandi AA, Vahedi E, Ghanei M. Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase. Daru, 2012; 20: 27.
45. Punithavathi D, Venkatesan N, Babu M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol. 2003; 139: 1342-1350.
46. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax, 1996a; 51: 348-350.
47. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radical Biol Med. 1996b; 21: 669-681.
48. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996; 154: 1055-1060.
49. Rahman I, Skwarska E, MacNee W. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 1997; 52: 565-568.
50. Ram A, Das M, Ghosh B. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull. 2003; 26: 1021-1024.
51. Sahebkar A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril. 2010; 94: e75-e76; author reply e77.
52. Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors 2013; 39: 197-208.
53. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis. Phytother Res. 2014a; 28: 633-642.
54. Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nat Rev Cardiol. 2014b; 11.
55. Sahebkar A. Low-density lipoprotein is a potential target for curcumin: novel mechanistic insights. Basic Clin Pharmacol Toxicol. 2014c; 114: 437-438.
56. Sahebkar A, Mohammadi A, Atabati A, Rahiman S, Tavallaie S, Iranshahi M, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M. Curcuminoids Modulate Pro-Oxidant-Antioxidant Balance but not the Immune Response to Heat Shock Protein 27 and Oxidized LDL in Obese Individuals. Phytother Res. 2013; 27: 1883-1888.
57. Schwartz J, Weiss ST. Dietary factors and their relation to respiratory symptoms. The second national health and nutrition examination survey. Am J Epidemiol. 1990; 132: 67-76.
58. Schwartz J, Weiss ST. Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am J Clin Nutr. 1994; 59: 110-114.
59. Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors 2013; 39: 69-77.
60. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 1998; 64: 353-356.
61. Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M, Harandi AA. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 2010; 188: 77-83.
62. Takahashi M, Suzuki K, Kim HK, Otsuka Y, Imaizumi A, Miyashita M, Sakamoto S. Effects of curcumin supplementation on exercise-induced oxidative stress in humans. Int J Sports Med. 2014; 35: 469-475.
63. Thresiamma KC, George J, Kuttan R. Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol. 1996; 34: 845-847.
64. Venkatesan N. Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci. 2000; 66: PL21-PL28.
65. Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem. 1995; 142: 79-87.
66. Venkatesan N, Punithavathi D, Babu M. Protection from acute and chronic lung diseases by curcumin. Adv Exp Med Biol. 2007; 595: 379-405.
67. Venkatesan N, Punithavathi V, Chandrakasan G. Curcumin protects bleomycin-induced lung injury in rats. Life Sci. 1997; 61: PL51-PL58.